We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iq-ai Limited | LSE:IQAI | London | Ordinary Share | JE00BD4H0R42 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.30 | 1.40 | 1.35 | 1.285 | 1.35 | 520,145 | 08:00:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Florists | 536k | -512k | -0.0028 | -4.82 | 2.47M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2020 10:10 | htps://pubs.rsna.org This is the journal entry add the t next to p | spurs90 | |
02/3/2020 10:06 | Any links to cv 19 Spurs ? | dave4545 | |
02/3/2020 10:04 | Buyers buying!!!! Moves quick | spurs90 | |
29/2/2020 13:55 | February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COVID-19) outbreak in China. This new tech includes artificial intelligence, analytics software, and using drones to make deliveries to hospitals, according to the healthcare market research firm GlobalData. htps://www.itnonline | spurs90 | |
29/2/2020 13:40 | February 26, 2020 — In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19). The researchers concluded that CT should be used as the primary screening tool for COVID-19 htps://www.itnonline | spurs90 | |
27/2/2020 15:08 | DOW,FTSE getting hammered again does not help, tin hats and all that! | hulk2004 | |
27/2/2020 15:07 | Spurs agree lots going on with IB and all positive,2 new consultants this year, one x FDBK, plenty of cash in the bank but this slow share price drip is painful if watching daily! | hulk2004 | |
27/2/2020 13:22 | For all doubting BIG NEWS ON THE WAY WATCH THE LAST INTERVIEW ON PROACTIVE INVESTORS FROM 2 minutes 38 seconds MAJOR CANCER SCIENCE WRAPPING UP BY END OF FIRST QUARTER | spurs90 | |
26/2/2020 20:19 | I like huge! | hulk2004 | |
26/2/2020 19:43 | Going huge | turbotrader2 | |
26/2/2020 17:35 | htps://www.ismrm.org Kathleen Schmainda presenting at the Mar 5 ISMRM Perfusion Study Group Virtual Meeting: Frontiers in Perfusion MRI: Dynamic Susceptibility Contrast Perfusion MRI: An Update on Clinical Applications in Brain Tumors. Now watch the last interview from 2.38 Michael says wrapping up major cancer science by end of q1 htps://www.proactive | spurs90 | |
26/2/2020 15:08 | Because he's 'Top AIM Stocks' and he's long from 10p and staring down the barrel of yet another massive loss. The best thing about his twitter feed is his fantastic ability to pick out stocks for everyone to go short on. | dplewis1 | |
23/2/2020 14:47 | Why you spamming | turbotrader2 | |
21/2/2020 16:30 | Barrow Neurological Institute / Dignity Health St. Joseph's Hospital and Medical Center has led the way in the development of cutting-edge diagnosis, treatment, and neurosurgical procedures for patients with brain tumors. Every year, Barrow treats thousands of patients with brain tumors, including some of the most difficult cases in the world. Since 1962, Barrow has grown into one of the premiere destinations in the world for neurology and neurosurgery. Experienced, highly skilled, and comprehensive teams of neurological specialists provide a complete spectrum of care-from diagnosis through outpatient neurorehabilitation- | spurs90 | |
21/2/2020 16:29 | From dec 18 rns IB Rad Tech offers customised workflows that automate the generation of sophisticated maps, outputs quality assurance indices, and can allow manual acknowledgement and intervention during intermediate processing steps. For example, one workflow used in generating quantitative Delta T1 and FTB maps relies on an exclusive machine-learned calibration technology termed "standardisation", which works for all platforms and field strengths. This step has proven superior to conventional normalisation techniques as it eliminates the need for the manual placement of regions of interest (ROIs) by radiology staff or physicians thereby reducing error and improving workflow efficiencies. David Smith, CEO of IB, said, "Using this automated normalisation algorithm within an IB Rad Tech workflow enables objective longitudinal assessment and can help assess whether a certain treatment protocol is working for brain tumor patients. Removing the variability of the manually-placed ROI is a more repeatable and faster method to do inter- and intra-study comparisons for multi-center clinical trials as well." "Without IB Rad Tech, we would not be able to process the high volume of studies we see at our site," said Dr. John Karis, MD, Director of MRI and brain imaging for the Department of Neuroradiology at Barrow Neurological Institute, Dignity Health St. Joseph's Hospital and Medical Center. "Our MR Technologists are now able to quickly and consistently generate IB's advanced maps, and the clinicians trust the science on which Delta T1 and FTBs are based", added Josef Debbins, PhD, Staff Scientist, Keller Center for Imaging Innovation at Barrow. | spurs90 | |
21/2/2020 13:40 | 1 day closer to stonechecker sale! But IB will be the game changer tong term. | hulk2004 | |
18/2/2020 10:50 | Buy and hold be patient game changing news on way listen to last interview pretty clear | spurs90 | |
18/2/2020 10:00 | The drift is disappointing but I am thinking that it is now at a level worth accumulating. | greyseal | |
18/2/2020 09:15 | This is becoming silly | turbotrader2 | |
16/2/2020 19:36 | Good to hear spurs, buy the dip so true lol | hulk2004 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions